Our findings further are consistent with prior work demonstrating similar plasma concentrations of triglycerides and cholesterol in mice with global aromatase deficiency and controls [27], though, in the prior study, global aromatase deficiency led to post-prandial hyperlipidemia after 36 weeks of age. The gene discussed is CYP19A1; the disease is hyperlipidemia.